TRUST DEPARTMENT MB FINANCIAL BANK N A - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TRUST DEPARTMENT MB FINANCIAL BANK N A ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2015$6,000
+20.0%
10,0000.0%0.00%0.0%
Q2 2015$5,000
-37.5%
10,0000.0%0.00%0.0%
Q1 2015$8,0000.0%10,0000.0%0.00%0.0%
Q4 2014$8,000
-78.4%
10,000
-75.0%
0.00%
-50.0%
Q3 2014$37,000
+117.6%
40,000
+100.0%
0.00%0.0%
Q2 2014$17,000
-65.3%
20,0000.0%0.00%
-71.4%
Q1 2014$49,00020,0000.01%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,200,000$858,0000.10%
SABBY MANAGEMENT, LLC 1,856,019$724,0000.04%
HOME FEDERAL BANK OF TENNESSEE 100,000$39,0000.03%
Cutter & CO Brokerage, Inc. 94,500$37,0000.02%
WADE G W & INC 80,000$31,0000.01%
Marcus Capital, LLC 15,000$6,0000.01%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$4,0000.01%
B. Riley Wealth Advisors, Inc. 28,000$11,0000.00%
Estate Counselors, LLC 10,000$4,0000.00%
Focused Wealth Management, Inc 2,955$1,0000.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders